Natus Medical has reported revenue of $37.3 million for the second quarter ended June 30, 2009, a decrease in comparison to $39.9 million in the second quarter of the previous year.
The company has reported a net income of $2.3 million, or $0.08 per diluted share, for the second quarter of 2009, a decrease in comparison to net income of $3.8 million, or $0.15 per diluted share, for the second quarter of 2008.
The company’s first half net income was $3.1 million, or $0.11 per diluted share, a decrease in comparison to net income of $6.4 million, or $0.26 per diluted share, for the comparable period in 2008.
Jim Hawkins, president and CEO of Natus Medical, said: “We are pleased with our second quarter results, even though our revenue was down compared to last year, as we were able to outperform on our expectations. This is extremely satisfying since we believe hospitals continue to significantly limit spending on capital equipment.
“The strength of our sales in the second quarter was across our newborn hearing, neurology, and newborn care product lines. Our international business also performed well. I am also happy to report that we generated $7m in cash during the quarter, he added.